Oxaliplatinum [Latin]
Oxaliplatinum [Latin] Brand names, Oxaliplatinum [Latin] Analogs
Oxaliplatinum [Latin] Brand Names Mixture
- No information avaliable
Oxaliplatinum [Latin] Chemical_Formula
Oxaliplatinum [Latin] RX_link
Oxaliplatinum [Latin] fda sheet
Oxaliplatinum [Latin] msds (material safety sheet)
Oxaliplatinum [Latin] Synthesis Reference
Oxaliplatinum [Latin] Molecular Weight
Oxaliplatinum [Latin] Melting Point
Oxaliplatinum [Latin] H2O Solubility
Oxaliplatinum [Latin] State
Oxaliplatinum [Latin] LogP
Oxaliplatinum [Latin] Dosage Forms
Oxaliplatinum [Latin] Indication
Oxaliplatinum [Latin] Pharmacology
Oxaliplatinum [Latin] Absorption
Oxaliplatinum [Latin] side effects and Toxicity
Oxaliplatinum [Latin] Patient Information
Patients and patientsí caregivers should be informed of the expected side effects of ELOXATIN, particularly its neurologic effects, both the acute, reversible effects, and the persistent neurosensory toxicity. Patients should be informed that the acute neurosensory toxicity may be precipitated or exacerbated by exposure to cold or cold objects. Patients should be instructed to avoid cold drinks, use of ice, and should cover exposed skin prior to exposure to cold temperature or cold objects.
Patients must be adequately informed of the risk of low blood cell counts and instructed to contact their physician immediately should fever, particularly if associated with persistent diarrhea, or evidence of infection develop.
Patients should be instructed to contact their physician if persistent vomiting, diarrhea, signs of dehydration, cough or breathing difficulties occur, or signs of allergic reaction appear.
![Oxaliplatinum_[Latin]](/images/rx/APRD00186.gif)
